PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

General OA media and info, page-556

  1. 565 Posts.
    lightbulb Created with Sketch. 106
    I have thought about this, and it seems to me

    1. unlikely that Bene, a family owned company, would be interested in such a deal
    They have kept the business in the family for many decades.

    2. How could you put a value on the transaction? Their income to date has been from sales totally unrelated to our repurposing trials, why should they share that with us? and we have no historical income data to base predictions on, we can only hazard a guess at it, assuming we get the green light.

    3. Without them we are nothing, and without us they continue to be Bene. Hardly negotiating from a position of strength.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.95M
Open High Low Value Volume
24.5¢ 25.5¢ 24.0¢ $258.1K 1.049M

Buyers (Bids)

No. Vol. Price($)
4 135166 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 101490 2
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.